J004-1403 Screening compound: 1-[2-(5-propyl-1,2-oxazol-3-yl)pyrrolidin-1-yl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]ethan-1-one

J004-1403 Screening compound: 1-[2-(5-propyl-1,2-oxazol-3-yl)pyrrolidin-1-yl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]ethan-1-one
J004-1403 Screening compound: 1-[2-(5-propyl-1,2-oxazol-3-yl)pyrrolidin-1-yl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]ethan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound J004-1403
1-[2-(5-propyl-1,2-oxazol-3-yl)pyrrolidin-1-yl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]ethan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

J004-1403

Molecular Formula

C20H25F3N4O2 (C20 H25 F3 N4 O2)

Compound Name

1-[2-(5-propyl-1,2-oxazol-3-yl)pyrrolidin-1-yl]-2-[3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]ethan-1-one

IUPAC name

1-[2-(5-propyl-12-oxazol-3-yl)pyrrolidin-1-yl]-2-[3-(trifluoromethyl)-4567-tetrahydro-1H-indazol-1-yl]ethan-1-one

SMILES

CCCc1cc(C(CCC2)N2C(Cn2nc(C(F)(F)F)c3c2CCCC3)=O)no1

InChI

InChI=1S/C20H25F3N4O2/c1-2-6-13-11-15(25-29-13)17-9-5-10-26(17)18(28)12-27-16-8-4-3-7-14(16)19(24-27)20(21,22)23/h11,17H,2-10,12H2,1H3/t17-/m0/s1

InChI Key

ZZVAGSYYUTZZLH-KRWDZBQOSA-N

MDL Number (MFCD)

MFCD18487627

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

410.44

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.655

Distribution Coefficient, logD

3.655

Water Solubility, LogSw

-3.77

Polar Surface Area

51.777

Acid Dissociation Constant (pKa)

21.85

Base Dissociation Constant (pKb)

-2.55

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

65.00

J004-1403 in Drug Discovery

Included in Screening Libraries

Antiviral Library (67538 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Targeted Diversity Library (40567 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with J004-1403 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound J004-1403?
Check Price and Availability of J004-1403, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of J004-1403 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for J004-1403
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for J004-1403
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of J004-1403 available by request